Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
D000293:Adolescent; D001315:Australia; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D002528:Cerebellar Neoplasms / Q000235:genetics / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008527:Medulloblastoma / Q000235:genetics / Q000473:pathology*; D010338:Pathology, Clinical / Q000458:organization & administration; D011237:Predictive Value of Tests; D011379:Prognosis; D016016:Proportional Hazards Models; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D018570:Risk Assessment; D012307:Risk Factors; D013048:Specimen Handling; D016019:Survival Analysis; D014481:United States
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases